Clinical Trial Update: A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors

View source ↗

Summary

Biogen is conducting an ongoing long-term safety study of omaveloxolone (BIIB141) in Friedreich's Ataxia patients who are being treated with the drug by their o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• BIIB141 (Omaveloxolone) (Omaveloxolone)

Snippet

Sponsor: Biogen | Conditions: Friedreich Ataxia | Status: RECRUITING